Manvi Biopharma Private Limited, a active private limited company, was established on 26 October 2018 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U74999TG2018PTC127913. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.33 M.
Employing 49 professional, Its leadership includes Gnana Supriya Gandavarapu (Director), Ramakanth Katta (Director), Varunkumarreddy Koduru (Director). Past directors included Midhunbabu Reddy Gandavarapu, Vijaya Laxmi Bangaru. It holds ₹1.28 M open charges and ₹3.40 Cr settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No.186/B, I.D.A., Mallapur, Hyderabad, Telangana, 500076.
U74999TG2018PTC127913
127913
26 October 2018
₹5.00 M
₹3.33 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Manvi Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gnana Supriya Gandavarapu | Director | 20 Feb 2020 | Current |
| Ramakanth Katta | Director | 21 Dec 2020 | Current |
| Varunkumarreddy Koduru | Director | 10 May 2019 | Current |
| Nagamani Kaperla | Director | 26 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Jan 2023 | Past |
| Pramod Abcsdd | Director | 15 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Manvi Biopharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 252.16% increase. The company also saw a substantial improvement in profitability, with a 722.08% increase in profit. The company's net worth Soared by an impressive increase of 3970.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Manvi Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,280,000.00
₹34,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2020 | The South Indian Bank Limited | ₹1.28 M | Open |
| 27 Dec 2019 | The South Indian Bank Limited | ₹3.40 Cr | Satisfied |
Explore comprehensive loan charge details -
Manvi Biopharma has a workforce of 49 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Manvi Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manvi Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Manvi Biopharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
The activity A charge registered on 27 Dec 2019 via Charge ID 100324763 with The South Indian Bank Limited was fully satisfied on 09 Sep 2021. was completed.
Progress on Manvi Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was documented.
The activity Ramakanth Katta was appointed as a Director was appointed as a Director on 21 Dec 2020 & has been associated with this company since 5 years 12 days . was completed.
The activity A charge with The South Indian Bank Limited of Rs. 34.00 M registered on 27 Dec 2019 with Charge ID 100324763 was modified on 08 Jun 2020. was completed.
Progress on A charge with The South Indian Bank Limited amounted to Rs. 1.28 M with Charge ID 100349655 was registered on 06 Mar 2020. was documented.
The CIN of Manvi Biopharma Private Limited is U74999TG2018PTC127913.
Manvi Biopharma Private Limited is headquartered at Plot No.186/B, I.D.A., Mallapur, Hyderabad, Telangana, 500076.
Manvi Biopharma Private Limited was incorporated on 26 October 2018.
The current directors of Manvi Biopharma Private Limited are
The primary industry of Manvi Biopharma Private Limited is Manufacturing.
Manvi Biopharma Private Limited is unlisted.
The authorized capital of Manvi Biopharma Private Limited is ₹5.00 M, and the paid-up capital is ₹3.33 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX